Net Income (Loss) Attributable to Parent in USD of Autolus Therapeutics plc from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Autolus Therapeutics plc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2016 to Q3 2025.
  • Autolus Therapeutics plc Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$79.1M, a 3.63% increase year-over-year.
  • Autolus Therapeutics plc Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$225M, a 16.8% increase year-over-year.
  • Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2024 was -$221M, a 5.89% decline from 2023.
  • Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2023 was -$208M, a 40% decline from 2022.
  • Autolus Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2022 was -$149M, a 4.75% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Autolus Therapeutics plc Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$225M -$79.1M +$2.98M +3.63% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$228M -$47.9M +$10.4M +17.8% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$238M -$70.2M -$17.5M -33.2% 01 Jan 2025 31 Mar 2025 10-Q 12 Aug 2025
Q4 2024 -$221M -$27.6M +$49.6M +64.2% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$270M -$82.1M -$36.2M -79.1% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$234M -$58.3M -$12.7M -27.9% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$221M -$52.7M -$12.9M -32.4% 01 Jan 2024 31 Mar 2024 10-Q 12 Aug 2025
Q4 2023 -$208M -$77.2M -$50.2M -186% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$158M -$45.8M -$3.08M -7.21% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$155M -$45.6M -$3.49M -8.31% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$152M -$39.8M -$2.75M -7.42% 01 Jan 2023 31 Mar 2023 10-Q 08 Aug 2024
Q4 2022 -$149M -$27M 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$42.8M 01 Jul 2022 30 Sep 2022 10-K 21 Mar 2024
Q2 2022 -$42.1M 01 Apr 2022 30 Jun 2022 10-K 21 Mar 2024
Q1 2022 -$37.1M -$3.8M -11.4% 01 Jan 2022 31 Mar 2022 10-K 21 Mar 2024
Q1 2021 -$145M -$33.3M -$3.39M -11.4% 01 Jan 2021 31 Mar 2021 6-K 06 May 2021
Q4 2020 -$142M -$42.9M -$1.92M -4.68% 01 Oct 2020 31 Dec 2020 20-F 07 Mar 2023
Q3 2020 -$140M -$37.3M -$10.1M -36.9% 01 Jul 2020 30 Sep 2020 6-K 05 Nov 2020
Q2 2020 -$130M -$32M -$3.57M -12.5% 01 Apr 2020 30 Jun 2020 6-K 06 Aug 2020
Q1 2020 -$127M -$29.9M -$2.69M -9.91% 01 Jan 2020 31 Mar 2020 6-K 06 May 2021
Q4 2019 -$124M -$40.9M -$20.3M -98.3% 01 Oct 2019 31 Dec 2019 20-F 10 Mar 2022
Q3 2019 -$104M -$27.2M -$14.4M -112% 01 Jul 2019 30 Sep 2019 6-K 05 Nov 2020
Q2 2019 -$89.2M -$28.5M -$20.8M -272% 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020
Q1 2019 -$68.3M -$27.2M -$10.5M -62.6% 01 Jan 2019 31 Mar 2019 6-K 06 Aug 2020
Q4 2018 -$57.9M -$20.6M -$13.1M -174% 01 Oct 2018 31 Dec 2018 20-F 04 Mar 2021
Q3 2018 -$44.8M -$12.9M 01 Jul 2018 30 Sep 2018 6-K 07 Nov 2019
Q2 2018 -$7.65M 01 Apr 2018 30 Jun 2018 6-K 08 Aug 2019
Q1 2018 -$16.7M 01 Jan 2018 31 Mar 2018 6-K 08 Aug 2019
Q4 2017 -$7.52M 01 Oct 2017 31 Dec 2017 20-F 25 Feb 2019

Autolus Therapeutics plc Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$221M -$12.3M -5.89% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$208M -$59.5M -40% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$149M -$6.74M -4.75% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$142M -$2K 0% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024
2020 -$142M -$18.2M -14.7% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023
2019 -$124M -$79.1M -177% 01 Jan 2019 31 Dec 2019 20-F 10 Mar 2022
2018 -$44.8M -$25M -127% 01 Oct 2017 30 Sep 2018 20-F 04 Mar 2021
2017 -$19.7M -$7.18M -57.2% 01 Oct 2016 30 Sep 2017 20-F 03 Mar 2020
2016 -$12.6M 01 Oct 2015 30 Sep 2016 20-F 25 Feb 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.